A Phase I Study to Assess the Pharmacokinetics Safety and Tolerability of a Single Dose of Ceftazidime-Avibactam (CAZ-AVI) in Children From 3 Months of Age to
-
- STATUS
- Not Recruiting
Updated on 19 February 2024
Summary
This is a study to find out more about a new drug, ceftazidime-avibactam (CAZ-AVI).
Description
This is a study to find out more about a new drug, ceftazidime-avibactam (CAZ-AVI).
Details
| Condition | Infections |
|---|---|
| Age | 1years - 18years |
| Clinical Study Identifier | TX3336 |
| Last Modified on | 19 February 2024 |
How understandable was the trial content above?
Hard to understand
Easy to understand
Similar trials to consider
Loading...
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.